These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9834004)

  • 1. The relative bioavailability and in vivo-in vitro correlations for four marketed carbamazepine tablets.
    Meyer MC; Straughn AB; Mhatre RM; Shah VP; Williams RL; Lesko LJ
    Pharm Res; 1998 Nov; 15(11):1787-91. PubMed ID: 9834004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bioinequivalence of carbamazepine tablets with a history of clinical failures.
    Meyer MC; Straughn AB; Jarvi EJ; Wood GC; Pelsor FR; Shah VP
    Pharm Res; 1992 Dec; 9(12):1612-6. PubMed ID: 1488405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative bioavailability study of zidovudine administered as two different tablet formulations in healthy adult subjects.
    Marier JF; Manthos H; Kebir S; Ferron S; DiMarco M; Morelli G; Tippabhotla SK; Vijan T; Singla AK; Garg M; Monif T
    Int J Clin Pharmacol Ther; 2006 May; 44(5):240-6. PubMed ID: 16724579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence of abacavir generic and innovator formulations under fasting and fed conditions.
    Marier JF; Borges M; Plante G; Dimarco M; Morelli G; Tippabhotla SK; Vijan T; Singla AK; Garg M; Monif T
    Int J Clin Pharmacol Ther; 2006 Jun; 44(6):284-91. PubMed ID: 16800101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers.
    Iqbal M; Khuroo A; Batolar LS; Tandon M; Monif T; Sharma PL
    Clin Ther; 2010 Mar; 32(3):588-96. PubMed ID: 20399995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of food and tablet age on relative bioavailability and pharmacodynamics of two tolbutamide products.
    Olson SC; Ayres JW; Antal EJ; Albert KS
    J Pharm Sci; 1985 Jul; 74(7):735-40. PubMed ID: 4032245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioequivalence of methylphenidate immediate-release tablets using a replicated study design to characterize intrasubject variability.
    Meyer MC; Straughn AB; Jarvi EJ; Patrick KS; Pelsor FR; Williams RL; Patnaik R; Chen ML; Shah VP
    Pharm Res; 2000 Apr; 17(4):381-4. PubMed ID: 10870979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative bioavailability and pharmacokinetic properties of two different enteric formulations of esomeprazole in healthy Bangladeshi male volunteers: An open-label, single-dose, randomized-sequence, two-way crossover study.
    Ullah MA; Shams-Ud-Dowla ; Maruf AA; Azad MA; Shohag MH; Sultana R; Latif AH; Hasnat A
    Clin Ther; 2010 Jul; 32(7):1419-26. PubMed ID: 20678688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative bioavailability of 2 tablet formulations of levodopa/benserazide in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study.
    Keller GA; Czerniuk P; Bertuola R; Spatz JG; Assefi AR; Di Girolamo G
    Clin Ther; 2011 Apr; 33(4):500-10. PubMed ID: 21635995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxcarbazepine final market image tablet formulation bioequivalence study after single administration and at steady state in healthy subjects.
    Flesch G; Tudor D; Souppart C; D'Souza J; Hossain M
    Int J Clin Pharmacol Ther; 2002 Nov; 40(11):524-32. PubMed ID: 12698990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative bioavailability study of carbamazepine tablets and a chewable tablet formulation.
    Maas B; Garnett WR; Pellock JM; Comstock TJ
    Ther Drug Monit; 1987; 9(1):28-33. PubMed ID: 3576660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and Bioequivalence Studies of a Newly Developed Branded Generic of Candesartan Cilexetil Tablets in Healthy Volunteers.
    Patel R; Palmer JL; Joshi S; Di Ció Gimena A; Esquivel F
    Clin Pharmacol Drug Dev; 2017 Sep; 6(5):492-498. PubMed ID: 27753282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of bioavailability and clinical efficacy of carbamazepine in epileptic patients.
    Silpakit O; Amornpichetkoon M; Kaojarern S
    Ann Pharmacother; 1997 May; 31(5):548-52. PubMed ID: 9161646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence of oxycodone hydrochoride extended release tablets to marketed reference products OxyContin® in Canada and US.
    Gosai P; Ducharme MP; Godfrey AR; Freeman JC; Monif T; Kumar KS; Kumar S; Mudnaik R; Katikaneni P
    Int J Clin Pharmacol Ther; 2013 Nov; 51(11):895-907. PubMed ID: 23673291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing real-life carbamazepine exposure between innovator and generic formulation.
    Gaïes E; Jebabli N; Zerei S; Charfi R; Salouage I; Ben Sassi M; El Jebari H; Daghfous R; Trabelsi S
    Therapie; 2022; 77(5):523-526. PubMed ID: 35184882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteers.
    Estevez-Carrizo FE; Parrillo S; Ercoli MC; Estevez-Parrillo FT
    Clin Ther; 2011 Jun; 33(6):738-45. PubMed ID: 21704238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative bioavailability of a generic capsule formulation of the reverse transcriptase inhibitor efavirenz and the innovator product.
    Marier JF; Morin I; Al-Numani D; Stiles M; Morelli G; Tippabhotla SK; Vijan T; Singla AK; Garg M; Di Marco M; Monif T
    Int J Clin Pharmacol Ther; 2006 Apr; 44(4):180-4. PubMed ID: 16625987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.